The Beta Cells in Diabetes podcast seeks to improve understanding among primary care physicians about the role of beta cells as key drivers in the development and progression of T2DM. Our goal is to engage primary care physicians in pathopysiology-based clinical decision making through an interactive educational format that stimulates debate and encourages physicians to incorporate the new science into their patient treatment regimens. By educating primary care physicians about the newest findings regarding beta cell treatment, we hope to positively affect the diabetes epidemic.
Dr. Schneider and Dr. Leahy, discuss the findings of the DCCT and EDIC studies as they relate to the impact of tight control of diabetes in the early...
Dr. Doron Schneider and Dr. Jack Leahy discuss The Diabetes and Complications Trial, a landmark study that still influences the standard of diabetes p...
Dr. Doron Schneider and Dr. Jack Leahy discuss the Diabetes Control and Complications Trial and the follow up study, EDIC. These landmark, studies per...
Doron Schneider, MD and Jack Leahy, MD discuss the importance of patient BMI and other risk factors for coronary artery disease when weighing treatmen...